cancer and semaglutide Disproportionality analysis of semaglutide-associated bile-duct cancer: A vigibase study | Indian Journal of Gastroenterology Could GLP-1 Drugs Reduce Obesity-Related
Description
The diabetes drug semaglutide has been making headline news ever since the medication received FDA approval to help with blood sugar control and obesity treatment
:max_bytes(150000):strip_icc()/VWHealth-Could-GLP-1Drugs-Reduce-Obesity-Related-Cancers-in-the-Future-3-7d602ab39c0448ddb00cd91b06be2a84.jpg)
He serves clients in Louisville and

Tea for weight loss, Apple weight, Health benefits

Menopause triggers hormonal changes that make weight gain more likely, even with diet and exercise
'I now walk an hour everyday, squeeze in 15 minutes of exercise, snack on salads, have dinner by 7 pm and sleep by 10 pm
Practical checklist (simple, scalable): Protein plan + resistance training from day 1 (protect lean mass) Dietitian touchpoint early for patients with poor appetite/food aversions Consider targeted labs in higher-risk patients (baseline + 36 months): vitamin D, ferritin/iron indices, B12 ( thiamine if vomiting/very low intake), plus others as clinically indicated Treat deficiencies proactivelydont wait for fatigue, hair loss, cramps, neuropathy, or plateau frustration Question for colleagues: Do you have a standard nutrition/lab monitoring protocol for GLP-1 patients or do you individualize completely
